KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Return on Invested Capital (2020 - 2025)

Biolife Solutions (BLFS) has disclosed Return on Invested Capital for 6 consecutive years, with 0.05% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Invested Capital fell 3.0% to 0.05% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.05%, a 3.0% decrease, with the full-year FY2025 number at 0.04%, down 3.0% from a year prior.
  • Return on Invested Capital was 0.05% for Q4 2025 at Biolife Solutions, up from 0.05% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.11% in Q3 2024 to a low of 239.25% in Q3 2023.
  • A 5-year average of 45.37% and a median of 0.03% in 2021 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: crashed -23900bps in 2023, then skyrocketed 23936bps in 2024.
  • Biolife Solutions' Return on Invested Capital stood at 0.02% in 2021, then crashed by -966407bps to 213.93% in 2022, then skyrocketed by 100bps to 0.0% in 2023, then crashed by -679bps to 0.01% in 2024, then tumbled by -254bps to 0.05% in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Return on Invested Capital are 0.05% (Q4 2025), 0.05% (Q3 2025), and 0.05% (Q2 2025).